MedPath

OLYMPUS CORPORATION

🇯🇵Japan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the OL-BF-001 for Severe Emphysema

Not Applicable
Terminated
Conditions
Emphysema
First Posted Date
2015-06-12
Last Posted Date
2019-08-28
Lead Sponsor
Olympus Corporation
Target Recruit Count
38
Registration Number
NCT02470052

Spectroscopy From Duodenum

Not Applicable
Completed
Conditions
Pancreatic Adenocarcinoma
First Posted Date
2012-12-20
Last Posted Date
2017-03-07
Lead Sponsor
Olympus Corporation
Target Recruit Count
445
Registration Number
NCT01753479
Locations
🇺🇸

Mayo Clinic Florida, Jacksonville, Florida, United States

🇺🇸

The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States

🇧🇪

Hôpital Erasme, Bruxelles, Brussels-Capital Region, Belgium

and more 1 locations

Pancreatic Juice Diagnosis From Duodenum

Not Applicable
Completed
Conditions
Pancreatic Adenocarcinoma
First Posted Date
2012-10-04
Last Posted Date
2015-09-21
Lead Sponsor
Olympus Corporation
Target Recruit Count
105
Registration Number
NCT01699698
Locations
🇺🇸

Mayo Clinic Jacksonville, Jacksonville, Florida, United States

🇯🇵

Kyushu University, Fukuoka-shi, Fukuoka-ken, Japan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.